127 related articles for article (PubMed ID: 16077972)
41. Theraputic targeting of Trk supresses tumor proliferation and enhances cisplatin activity in HNSCC.
Yilmaz T; Jiffar T; de la Garza G; Lin H; Milas Z; Takahashi Y; Hanna E; MacIntyre T; Brown JL; Myers JN; Kupferman ME
Cancer Biol Ther; 2010 Sep; 10(6):644-53. PubMed ID: 20703101
[TBL] [Abstract][Full Text] [Related]
42. Cisplatin-induced growth arrest of head and neck cancer cells correlates with increased expression of p16 and p53.
Yip HT; Chopra R; Chakrabarti R; Veena MS; Ramamurthy B; Srivatsan ES; Wang MB
Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):317-26. PubMed ID: 16549753
[TBL] [Abstract][Full Text] [Related]
43. Betulinic Acid Suppresses Ovarian Cancer Cell Proliferation through Induction of Apoptosis.
Lee D; Lee SR; Kang KS; Ko Y; Pang C; Yamabe N; Kim KH
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31277238
[TBL] [Abstract][Full Text] [Related]
44. Sensitization of head and neck cancer to cisplatin through the use of a novel curcumin analog.
Abuzeid WM; Davis S; Tang AL; Saunders L; Brenner JC; Lin J; Fuchs JR; Light E; Bradford CR; Prince ME; Carey TE
Arch Otolaryngol Head Neck Surg; 2011 May; 137(5):499-507. PubMed ID: 21576562
[TBL] [Abstract][Full Text] [Related]
45. A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer.
Kumar B; Yadav A; Hideg K; Kuppusamy P; Teknos TN; Kumar P
PLoS One; 2014; 9(3):e93208. PubMed ID: 24675768
[TBL] [Abstract][Full Text] [Related]
46. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation.
Tan Y; Yu R; Pezzuto JM
Clin Cancer Res; 2003 Jul; 9(7):2866-75. PubMed ID: 12855667
[TBL] [Abstract][Full Text] [Related]
47. PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells.
Kim J; Guan J; Chang I; Chen X; Han D; Wang CY
Mol Cancer Ther; 2010 Jul; 9(7):1977-84. PubMed ID: 20571067
[TBL] [Abstract][Full Text] [Related]
48. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
Liu T; Peng H; Zhang M; Deng Y; Wu Z
Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353
[TBL] [Abstract][Full Text] [Related]
49. Chemopreventive effect of Betulinic acid via mTOR -Caspases/Bcl2/Bax apoptotic signaling in pancreatic cancer.
Guo Y; Zhu H; Weng M; Wang C; Sun L
BMC Complement Med Ther; 2020 Jun; 20(1):178. PubMed ID: 32513155
[TBL] [Abstract][Full Text] [Related]
50. Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells.
Tuttle TR; Takiar V; Kumar B; Kumar P; Ben-Jonathan N
Cancer Lett; 2017 Mar; 389():33-40. PubMed ID: 28025101
[TBL] [Abstract][Full Text] [Related]
51. Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.
Uehara T; Kanazawa T; Mizukami H; Uchibori R; Tsukahara T; Urabe M; Kume A; Misawa K; Carey TE; Suzuki M; Ichimura K; Ozawa K
Cancer Sci; 2014 Jan; 105(1):72-80. PubMed ID: 24168112
[TBL] [Abstract][Full Text] [Related]
52. Sensitization for anticancer drug-induced apoptosis by betulinic Acid.
Fulda S; Debatin KM
Neoplasia; 2005 Feb; 7(2):162-70. PubMed ID: 15802021
[TBL] [Abstract][Full Text] [Related]
53. Induction of apoptosis and sensitization of head and neck squamous carcinoma cells to cisplatin by targeting survivin gene expression.
Khan Z; Tiwari RP; Khan N; Prasad GB; Bisen PS
Curr Gene Ther; 2012 Dec; 12(6):444-53. PubMed ID: 22974420
[TBL] [Abstract][Full Text] [Related]
54. Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.
Gelbard A; Garnett CT; Abrams SI; Patel V; Gutkind JS; Palena C; Tsang KY; Schlom J; Hodge JW
Clin Cancer Res; 2006 Mar; 12(6):1897-905. PubMed ID: 16551875
[TBL] [Abstract][Full Text] [Related]
55. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
56. Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma.
Theile D; Gal Z; Warta R; Rigalli JP; Lahrmann B; Grabe N; Herold-Mende C; Dyckhoff G; Weiss J
Cancer Biol Ther; 2014 Apr; 15(4):436-42. PubMed ID: 24448417
[TBL] [Abstract][Full Text] [Related]
57. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
58. Down-regulation of multiple cell survival proteins in head and neck cancer cells by an apoptogenic mutant of adenovirus type 5.
Vijayalingam S; Subramanian T; Ryerse J; Varvares M; Chinnadurai G
Virology; 2009 Sep; 392(1):62-72. PubMed ID: 19631957
[TBL] [Abstract][Full Text] [Related]
59. Effect of electrochemotherapy with betulinic acid or cisplatin on regulation of heat shock proteins in metastatic human carcinoma cells in vitro.
Mączyńska J; Choromańska A; Kutkowska J; Kotulska M; Zalewski M; Zalewski J; Kulbacka J; Saczko J
Oncol Rep; 2019 Jun; 41(6):3444-3454. PubMed ID: 31002374
[TBL] [Abstract][Full Text] [Related]
60. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.
Zhao Z; Wang H; Zhang L; Mei X; Hu J; Huang K
Anticancer Drugs; 2017 Feb; 28(2):187-196. PubMed ID: 27831944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
